Study: Denying anti-depressants for teens, young adults raises risk of suicides
Government warnings a decade ago about the risks associated with children and adolescents taking anti-depressants, such as Paxil and Zoloft, appear to have backfired — causing an increase in suicide attempts and discouraging many depressed young people from seeking treatment, according to a study published on Wednesday.
Because of FDA warnings about SSRIs — selective serotonin reuptake inhibitors — anti-depressant prescriptions fell sharply for adolescents ages 10 to 17 and for young adults ages 18 to 29. At the same time, researchers found that the number of suicide attempts rose by more than 20 percent in adolescents and by more than a third in young adults.
Show commenting policy
TribLive commenting policy
- Blizzard-stricken East digs out amid forecast 2nd-guessing
- Pittsburgh travelers feel effects of Northeast blizzard
- Orcas could land on endangered list
- Santa Ana winds cut power to thousands in Southern California
- Medicare payments to tie doctor, hospital payments to quality rather than volume of care
- Pentagon puts ‘fork’ in news about ex-captive Bergdahl
- Slain Ga. couple known for charity projects
- House sales tax proposal criticized as attack on states’ rights
- Boehner acknowledges early House GOP ‘stumbles’
- Wisconsin’s Walker takes first step toward possible run in 2016
- Dems delay Iran sanctions proposal